Addyi Alternatives for Low Libido in Women
What are the alternatives to Addyi for low libido in women?
Reviewed by Taylor Anderson, RN
Aesthetic Registered Nurse
Taylor Anderson is an aesthetic registered nurse and a reviewer for Hot or Nothing.
Updated November 17, 2026
Quick answer
For low libido when Addyi isn't working or a nightly pill doesn't suit you, the main alternatives are Vyleesi, testosterone and bupropion. Vyleesi is an FDA-approved shot taken only before sex, for women before menopause. After menopause, Addyi is approved for women under 65, Vyleesi is not, and a testosterone patch can mean more satisfying sex.
Want to feel turned on again? See which libido options fit you and what they cost.
See My PlanIn this guide
Key takeaways
- The main alternatives to Addyi for low libido are Vyleesi, testosterone and bupropion, and each one differs in how you take it and who it suits.
- Addyi is a pill you take every night at bedtime for months before you know whether it works, and you have to time any drinks around your dose.
- Vyleesi is a shot you take only before sex, for women who haven't gone through menopause, and a 4-dose box costs $99 without insurance coverage through BlinkRx (vyleesi.com, November 2026).
- If you are past menopause and under 65, Addyi is approved for you and Vyleesi is not, and a testosterone patch can bring more satisfying sex each month, with more unwanted hair growth and unknown long-term effects on the breasts.
- Most women in the threads we read who named a libido treatment talked about estrogen or HRT, so tell your clinical team what changed and when, so your plan matches the cause.
If low libido is the problem and Addyi isn't working for you, or a nightly pill doesn't fit your life, the main alternatives are Vyleesi (bremelanotide), testosterone and bupropion. Vyleesi is FDA-approved for premenopausal women, and it is a shot you take only before sex. Past menopause, Vyleesi isn't labeled for you, and testosterone is the alternative with a large trial behind it.
You can see every libido option on our libido hub, or read the wider list of low libido treatments for women.
What can you take instead of Addyi?
The alternatives are Vyleesi, testosterone and bupropion. Each one differs from Addyi in how you take it and in who it was studied in.
| Option | FDA status | How you take it | Who it was studied in | Trial, size and length | Time to first change | Main side effects | Price, seller and month |
|---|---|---|---|---|---|---|---|
| Addyi (flibanserin) | Approved for "women less than 65 years of age with acquired, generalized hypoactive sexual desire disorder (HSDD)" (Addyi label) | 100 mg pill once daily at bedtime | Premenopausal women, and postmenopausal women aged 39 to 64 | Three 24-week placebo-controlled trials in premenopausal women. Study 6: 24 weeks, 447 postmenopausal women on Addyi and 455 on placebo (Addyi label) | Results judged at week 24 | Dizziness, sleepiness, nausea. Boxed warning for severe low blood pressure and fainting with alcohol | $149 a month without insurance through PhilRx with free shipping, or as little as $20 a month with commercial insurance for eligible patients (addyi.com, November 2026) |
| Vyleesi (bremelanotide) | Approved for "premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)" and "not indicated for the treatment of HSDD in postmenopausal women" (Vyleesi label) | 1.75 mg autoinjector shot in the belly or thigh at least 45 minutes before sex. No more than one dose in 24 hours and no more than 8 a month | Premenopausal women, average age 39 | RECONNECT: two identical 24-week trials, 1,267 women (Vyleesi label) | Week 4, the first check | Nausea, flushing, headache | $99 for a 4-dose box without insurance coverage through BlinkRx. Most commercially insured patients pay $0. At the label's limit of 8 doses a month, that is two boxes, or $198 without coverage (vyleesi.com, November 2026) |
| Testosterone | Off-label for women's low desire | Skin patch. The trial's higher dose delivered 300 µg a day | Postmenopausal women not taking estrogen | APHRODITE: 814 women, 52 weeks, results measured at 24 weeks (NEJM) | By the second month | Unwanted hair growth | Not in our price check |
| Bupropion | Off-label for low desire | Extended-release pill once a day | Not covered here | Not covered here | Not covered here | Not covered here | Not in our price check |
Prices checked November 2026 on each seller's own site.
Hot or Nothing is a third route. Our clinical team can prescribe PT-141, kisspeptin or bioidentical estrogen if one fits your goal, and you start with the quiz.
How long does Addyi take to work?
Addyi's trials judged results after 24 weeks of a pill every night at bedtime, according to the Addyi label. That means months of nightly doses before you know whether it is working, and that wait is the main reason women look at alternatives.
The payoff is also narrower than many women expect. Addyi raised the number of satisfying sexual events in all three premenopausal trials. In two of those trials, though, desire tracked in a daily diary did not beat placebo. Desire measured by questionnaire did improve in all three.
Side effects show up early. Most began within the first 14 days. Alcohol rules come with the pill. If you have one or two drinks, wait at least two hours before your bedtime dose. If you have three or more drinks that evening, skip the dose. After your dose, drink nothing more until the next day.
For contrast, women in the Vyleesi RECONNECT trials (Obstet Gynecol 2019) showed a change in desire at the first check, week 4, and it lasted through the study. These were separate trials, not a head-to-head test. That comparison shows when each set of trials checked results. It does not show which drug works faster.
Is Vyleesi better than Addyi?
Neither drug is proven better, because no trial has compared Vyleesi with Addyi head to head. In separate trials, the boost in desire over placebo landed in a similar range for both drugs. The real differences are how you take them and who they are approved for.
Vyleesi raised desire and lowered distress about low desire, but it did not raise the number of satisfying sexual events. Addyi did raise them in its premenopausal trials. If more satisfying sex each month is your main goal, that difference counts.
Here is what taking Vyleesi involves. Nausea is the side effect to plan for. It is most common with the first shot and usually lasts about two hours, according to the Vyleesi label. Taking the anti-nausea drug ondansetron beforehand did not help, but your clinical team can prescribe something for nausea after it starts.
Vyleesi briefly raises blood pressure and lowers heart rate after each dose, usually for up to 12 hours. It is not for women with uncontrolled high blood pressure or known heart disease. Using it often can darken skin on the face, gums or breasts, and the darkening may not fade. Ask your clinical team what to watch for. For more detail on the shot-versus-pill trade-offs, read PT-141 vs Addyi for low libido.
What can you take for low libido after menopause?
If you are past menopause and under 65, Addyi is labeled for you and Vyleesi is not. Addyi's label added that use in December 2025, based on a 24-week trial in postmenopausal women aged 39 to 64 that improved its main results (Addyi label).
Testosterone is the alternative with a large postmenopausal trial behind it. In APHRODITE, 814 women who were not taking estrogen used a patch for 52 weeks. On the 300 µg dose, satisfying sex went up by 2.1 times a month, compared with 0.7 on placebo. By week 24, 78% of their sexual encounters were satisfying, compared with 65% on placebo. The 150 µg dose did not beat placebo on satisfying sex, though both doses raised desire and lowered distress.
Testosterone has trade-offs. Unwanted hair growth was more common, at 30.0% on the 300 µg dose compared with 23.1% on placebo. Four women on testosterone were diagnosed with breast cancer, compared with none on placebo. One of those diagnoses came in the first 4 months, and one woman had symptoms before the trial began. The authors write that "the long-term effects of testosterone, including effects on the breast, remain uncertain." Your clinical team checks whether it fits your health history. Read more in Is testosterone worth it for women's low libido?
Bupropion is another pill, and it is off-label for low desire.
What women share
We read 166 threads on r/TwoXChromosomes, r/Perimenopause and r/Menopause from October 2025 to October 2026. 52 of them named a treatment for low libido. Most of those, 42 of 52, talked about estrogen or HRT, and 18 of 52 mentioned testosterone. Only 2 mentioned Addyi, and 1 mentioned Vyleesi or PT-141.
Some women describe desire fading inside a long relationship and then wondering whether the relationship is the cause. One woman on r/TwoXChromosomes wrote: "I've heard of far too many women who feel broken or wrong when they lose their libido in a LTR, only to later discover it was because they were ready to leave it." (I thought my low libido was a problem. Then my relationship ended)
That matters when you choose a drug. Addyi and Vyleesi were approved for low desire that is "NOT due to: a co-existing medical or psychiatric condition, problems with the relationship, or the effects of a medication or drug substance" (Vyleesi label, with the same wording in the Addyi label). Tell your clinical team what changed and when, so your plan matches the cause.
You want to feel turned on again, and the right option depends on whether you have gone through menopause, how you want to take it and your health history. Take the quiz and pick the libido goal. Your clinical team will look at which plan fits, including PT-141, kisspeptin or bioidentical estrogen if one suits you. You can also compare every option on the libido hub.
Ready to make a move?
Answer three questions to see the treatment options that fit your goals.
See My PlanFAQ
Does Addyi work for women after menopause?
Yes, Addyi is approved for women past menopause who are under 65. The label added that use in December 2025, based on a 24-week trial in postmenopausal women aged 39 to 64 that improved its main results. Vyleesi is not approved after menopause, and a testosterone patch is the other option with a large trial in women past menopause.
Can you drink alcohol on Addyi?
You can, but you have to time it around your bedtime dose. After one or two drinks, wait at least two hours before taking Addyi, and if you have three or more drinks that evening, skip the dose. After your dose, drink nothing more until the next day. Mixing Addyi and alcohol can cause severe low blood pressure and fainting.
How much is Vyleesi without insurance?
Vyleesi costs $99 for a 4-dose box without insurance coverage through BlinkRx, according to vyleesi.com, checked November 2026. At the label's limit of 8 doses a month, that is two boxes, or $198. Most commercially insured patients pay $0 for a 4-dose box.
Is testosterone safe for women with low libido?
Testosterone raised satisfying sex and desire in a large patch trial in women past menopause, but its long-term effects, including on the breasts, are still uncertain. Unwanted hair growth was more common on the higher dose, and four women on testosterone were diagnosed with breast cancer compared with none on placebo, though one diagnosis came in the first 4 months and one woman had symptoms before the trial began. Testosterone is off-label for women's low desire, so your clinical team checks whether it fits your health history.
Keep reading
Sources (5)
- Testosterone for Low Libido in Postmenopausal Women ... · nejm.org · captured November 17, 2026
- Revised: 12/2025 · accessdata.fda.gov · captured November 17, 2026
- -------------------------DOSAGE AND ADMINISTRATION--------------------- treatment and ensure blood pressure is well-controlled. VYLEESI is not recommended in patients at high risk for cardiovascular disease. (5.1) · accessdata.fda.gov · captured November 17, 2026
- How to Get Addyi® & Save on Costs | Addyi® (flibanserin) · addyi.com · captured November 17, 2026
- Vyleesi | Bremelanotide Injection | HSDD Prescription Treatment · vyleesi.com · captured November 17, 2026
